Chemistry 250 Course: Advances in Pharmaceutical Research
Noyes 153 (J. Holmes Sturdivant Lecture Hall)
Discovery and Development of Halaven, a Fully Synthetic Macrocyclic Ketone Analog of Halichondrin B, for the Treatment of Late-Stage Breast Cancer and Soft-Tissue Sarcoma
Frank Fang,
Dr., Ph.D., Vice-President,
Process Research & Development,
Eisai, Inc.,
For more information, please contact Lynne Martinez by phone at 626-395-4004 or by email at [email protected].